DK69887D0 - Dichloranilinderivater - Google Patents

Dichloranilinderivater

Info

Publication number
DK69887D0
DK69887D0 DK069887A DK69887A DK69887D0 DK 69887 D0 DK69887 D0 DK 69887D0 DK 069887 A DK069887 A DK 069887A DK 69887 A DK69887 A DK 69887A DK 69887 D0 DK69887 D0 DK 69887D0
Authority
DK
Denmark
Prior art keywords
dichloraniline
derivatives
dichloraniline derivatives
Prior art date
Application number
DK069887A
Other languages
English (en)
Other versions
DK163991C (da
DK69887A (da
DK163991B (da
Inventor
Lawrence Henry Charles Lunts
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DK69887D0 publication Critical patent/DK69887D0/da
Publication of DK69887A publication Critical patent/DK69887A/da
Publication of DK163991B publication Critical patent/DK163991B/da
Application granted granted Critical
Publication of DK163991C publication Critical patent/DK163991C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
DK069887A 1986-02-12 1987-02-11 Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne DK163991C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8603475 1986-02-12
GB868603475A GB8603475D0 (en) 1986-02-12 1986-02-12 Chemical compounds

Publications (4)

Publication Number Publication Date
DK69887D0 true DK69887D0 (da) 1987-02-11
DK69887A DK69887A (da) 1987-08-13
DK163991B DK163991B (da) 1992-04-27
DK163991C DK163991C (da) 1992-09-21

Family

ID=10592944

Family Applications (1)

Application Number Title Priority Date Filing Date
DK069887A DK163991C (da) 1986-02-12 1987-02-11 Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne

Country Status (37)

Country Link
US (1) US4937251A (da)
JP (2) JPS62258359A (da)
KR (1) KR870007886A (da)
CN (1) CN1020095C (da)
AT (1) AT394364B (da)
AU (1) AU596824B2 (da)
BE (1) BE1002129A3 (da)
CA (1) CA1301762C (da)
CH (1) CH670636A5 (da)
CS (1) CS402991A3 (da)
CY (1) CY1660A (da)
DE (1) DE3704223C2 (da)
DK (1) DK163991C (da)
ES (1) ES2004676A6 (da)
FI (1) FI83774C (da)
FR (1) FR2596049B1 (da)
GB (2) GB8603475D0 (da)
GR (1) GR870220B (da)
HK (1) HK85790A (da)
HU (1) HU199416B (da)
IE (1) IE59524B1 (da)
IL (2) IL81535A (da)
IS (1) IS1489B (da)
IT (1) IT1205978B (da)
LU (1) LU86768A1 (da)
MX (1) MX5220A (da)
NL (1) NL188408C (da)
NO (1) NO170629C (da)
NZ (1) NZ219241A (da)
PH (1) PH24067A (da)
PL (1) PL151050B1 (da)
PT (1) PT84273B (da)
SE (1) SE462562B (da)
SG (1) SG70590G (da)
SU (1) SU1590042A3 (da)
ZA (1) ZA87974B (da)
ZW (1) ZW2887A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
GB8718939D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds
US5149698A (en) * 1987-08-11 1992-09-22 Glaxo Group Limited Chloroaniline derivatives
DE3880628T2 (de) * 1987-11-13 1993-08-05 Glaxo Group Ltd Phenethanolamin-derivate.
EP0460924A1 (en) * 1990-06-05 1991-12-11 Glaxo Group Limited Dichloroaniline compound
GB9104650D0 (en) * 1991-03-05 1991-04-17 Glaxo Group Ltd Medicaments
US6419873B1 (en) 1999-03-19 2002-07-16 Q2100, Inc. Plastic lens systems, compositions, and methods
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
TWI249515B (en) 2001-11-13 2006-02-21 Theravance Inc Aryl aniline beta2 adrenergic receptor agonists
DE10392748B4 (de) * 2002-06-18 2010-12-23 Asahi Kasei Emd Corporation Strommessverfahren und Strommessvorrichtung
US20070219223A1 (en) * 2006-03-07 2007-09-20 Endacea, Inc. Compositions and methods for treating respiratory disorders
JP5626621B2 (ja) 2010-03-19 2014-11-19 株式会社 日立産業制御ソリューションズ フェイズドアレイ合成開口ソナーシステム
ES2790358T3 (es) 2011-12-28 2020-10-27 Global Blood Therapeutics Inc Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
CA2860323C (en) 2011-12-28 2022-03-08 The Regents Of The University Of California Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
AP2015008718A0 (en) 2013-03-15 2015-09-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CN111454200A (zh) 2013-03-15 2020-07-28 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
WO2014145040A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20160083343A1 (en) 2013-03-15 2016-03-24 Global Blood Therapeutics, Inc Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
PE20201444A1 (es) 2014-02-07 2020-12-10 Global Blood Therapeutics Inc Polimorfos cristalinos de la base libre de 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)piridin-3-il)metoxi)benzaldehido
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
WO2017096230A1 (en) 2015-12-04 2017-06-08 Global Blood Therapeutics, Inc. Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
TWI752307B (zh) 2016-05-12 2022-01-11 美商全球血液治療公司 新穎化合物及製造化合物之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1618005A1 (de) * 1966-09-22 1971-09-09 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-dihalogen-phenyl-aethylaminen
NL176168C (nl) * 1972-12-18 1985-03-01 Thomae Gmbh Dr K Werkwijze ter bereiding respectievelijk vervaardiging van een farmaceutisch preparaat en werkwijze ter bereiding van daarbij bruikbare nieuwe gesubstitueerde 1-(4-aminofenyl)-2-amino-ethanol-derivaten die, behalve een analgetische, uterusspasmolytische en anti-spastische werking op de dwarsgestreepte spieren, in het bijzonder een betaŸ2-mimetische en/of betaŸ1-blokkerende werking bezitten.
DE2711655A1 (de) * 1977-03-17 1978-09-21 Basf Ag Pyridinyl-aminoalkylaether
CH635320A5 (en) * 1978-01-01 1983-03-31 Ciba Geigy Ag 1-(Azacyclic aralkoxyphenyl)-2- or -3-(bis-arylalkylamino)alkanes
EP0021636B1 (en) * 1979-06-16 1982-12-01 Beecham Group Plc Secondary amines, their preparation and use in pharmaceutical compositions
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
US4379166A (en) * 1981-08-03 1983-04-05 Schering Corporation Arylmethoxy-, arylmethylthio-, heteroarylmethoxy-, and heteroarylmethylthio-alkylaminoalcohols
HU186654B (en) * 1982-12-28 1985-09-30 Richter Gedeon Vegyeszet Process for producing new pyridine derivatives, acid additional salts and quaternary salts and pharmaceutical compositions containing them
DE3434271A1 (de) * 1984-09-19 1986-03-20 Beiersdorf Ag, 2000 Hamburg Substituierte 3,4-dihydro-chinolin-2(1h)-one verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
GB8525484D0 (en) * 1985-10-16 1985-11-20 Glaxo Group Ltd Chemical compounds
GB8718939D0 (en) * 1987-08-11 1987-09-16 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
FI870554A (fi) 1987-08-13
JPS62258359A (ja) 1987-11-10
AU596824B2 (en) 1990-05-17
SE8700535L (sv) 1987-08-13
LU86768A1 (fr) 1988-03-02
FI83774C (fi) 1991-08-26
NL188408B (nl) 1992-01-16
KR870007886A (ko) 1987-09-22
ATA28687A (de) 1991-09-15
GB2187734B (en) 1990-05-30
DK163991C (da) 1992-09-21
CA1301762C (en) 1992-05-26
PT84273B (pt) 1989-09-14
GB8703059D0 (en) 1987-03-18
IL81535A0 (en) 1987-09-16
US4937251A (en) 1990-06-26
GB8603475D0 (en) 1986-03-19
CH670636A5 (da) 1989-06-30
NO170629B (no) 1992-08-03
PT84273A (en) 1987-03-01
PL151050B1 (en) 1990-07-31
FI870554A0 (fi) 1987-02-11
IE59524B1 (en) 1994-03-09
SG70590G (en) 1990-10-26
AU6869587A (en) 1987-08-13
IL89205A (en) 1993-04-04
BE1002129A3 (fr) 1990-07-24
IT1205978B (it) 1989-04-05
CY1660A (en) 1993-05-14
IT8747630A0 (it) 1987-02-11
SU1590042A3 (ru) 1990-08-30
DK69887A (da) 1987-08-13
NO170629C (no) 1992-11-11
NZ219241A (en) 1990-01-29
SE8700535D0 (sv) 1987-02-11
AT394364B (de) 1992-03-25
ZW2887A1 (en) 1987-09-23
GR870220B (en) 1987-05-28
ZA87974B (en) 1987-12-30
IS1489B (is) 1992-06-30
FR2596049B1 (fr) 1991-02-08
HK85790A (en) 1990-10-25
HU199416B (en) 1990-02-28
NL188408C (nl) 1992-06-16
CN1020095C (zh) 1993-03-17
JPH0462311B2 (da) 1992-10-05
DK163991B (da) 1992-04-27
PL264054A1 (en) 1988-10-13
NL8700326A (nl) 1987-09-01
IL81535A (en) 1990-11-05
JPH0314565A (ja) 1991-01-23
HUT43566A (en) 1987-11-30
ES2004676A6 (es) 1989-02-01
CS402991A3 (en) 1992-09-16
SE462562B (sv) 1990-07-16
FI83774B (fi) 1991-05-15
IE870350L (en) 1987-08-12
FR2596049A1 (fr) 1987-09-25
IS3193A7 (is) 1987-08-13
DE3704223A1 (de) 1987-08-20
CN87101830A (zh) 1987-09-09
DE3704223C2 (de) 1995-05-24
NO870526D0 (no) 1987-02-11
GB2187734A (en) 1987-09-16
PH24067A (en) 1990-03-05
MX5220A (es) 1993-11-01
NO870526L (no) 1987-08-13

Similar Documents

Publication Publication Date Title
DK263587A (da) Imidazoquinolinyletherderivater
DK82087D0 (da) Pyrocatecholderivater
DK69887A (da) Dichloranilinderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
AT399804B (de) Sportschuh
TR26815A (tr) Azolilmetil-sikropil türevleri
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188D0 (da) Cholecalciferolderivater
DK693587A (da) Alkansulfonanilidderivater
DK81888D0 (da) Dibenzoxepinderivater
DK378088A (da) Alkenderivater
DK49688A (da) Propiolophenonderivater
DK691287D0 (da) 5-floururacilderivater
DK210487D0 (da) Substituerede benzimidazolderivater
DK444687A (da) Alfa-substituerede ketonitron-derivater
DK271088A (da) Tienopyridinderivater
DK229887D0 (da) Alkenamidderivater
DK619187A (da) Isoindolderivater
DK440687D0 (da) Bicyclooctanderivater
DK695788D0 (da) Naphtalenderivater
ATA246886A (de) Schachtsystem
DK435087A (da) Isoprenderivater
DK440787D0 (da) Bicyclooctanderivater
DK71488A (da) Dipenylethylen-derivater
DK733688A (da) Dioxazocinderivater